Filing Details
- Accession Number:
- 0000950170-25-011850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 17:00:06
- Reporting Period:
- 2025-01-30
- Accepted Time:
- 2025-01-31 17:00:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185858 | David Baltimore | C/O Regulus Therapeutics Inc. 4224 Campus Point Court #210 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-30 | 19,610 | $1.06 | 22,169 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $1.06, and the range of prices were between $0.97 and $1.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each price will be provided.
Billionaire Hedge Funds
